tiprankstipranks
Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
US Market
DMII
Drugs Made In America Acquisition II Corp.
RESEARCH TOOLSreports

Drugs Made In America Acquisition II Corp. (DMII) Financial Statements

1 Followers

Drugs Made In America Acquisition II Corp. Financial Overview

Drugs Made In America Acquisition II Corp.'s market cap is currently $640.82M. The company's EPS TTM is $0.05; its P/E ratio is 28.73; Drugs Made In America Acquisition II Corp. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -1.30M$ -151.72K
EBITDA$ -1.30M$ -151.72K
Net Income$ 4.19M$ -151.72K
Balance Sheet
Cash & Short-Term Investments$ 223.00$ 17.04K
Total Assets$ 504.96M$ 138.06K
Total Debt$ 0.00$ 250.10K
Net Debt$ -223.00$ 233.06K
Total Liabilities$ 17.80M$ 254.78K
Stockholders' Equity$ 487.16M$ -116.72K
Cash Flow
Free Cash Flow$ -1.02M$ -194.30K
Operating Cash Flow$ -1.02M$ -194.30K
Investing Cash Flow$ -500.00M$ 0.00
Financing Cash Flow$ 501.00M$ 211.33K
Currency in USD

Drugs Made In America Acquisition II Corp. Earnings and Revenue History

Income Statement >

Drugs Made In America Acquisition II Corp. Debt to Assets

Balance Sheet >

Drugs Made In America Acquisition II Corp. Cash Flow

Cash Flow >

Drugs Made In America Acquisition II Corp. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >